CA
SCMP

Calton & Associates’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Calton & Associates’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-178
Closed -$3K – 1508
2017
Q4 		$3K Buy
+178
New +$2.19K ﹤0.01% 1377

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Calton & Associates's SCMP Position: Q1 2018 in Review

Calton & Associates sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 178 shares — an estimated $3K sold.

Calton & Associates first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Calton & Associates reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 178 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3K.
  • Calton & Associates first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's Sucampo Pharmaceuticals, Inc. position peaked at $3K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.